NEW YORK — The Food and Drug Administration has approved expanded use of Pfizer Inc.’s blockbuster cholesterol-lowering medicine Lipitor by five new categories, including one to reduce the risk of non ...

Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease NEW YORK, March 7 -- Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved ...

Cholesterol disorders affect millions of people globally and are among the leading risk factors for cardiovascular diseases, including heart attack and stroke. Statins are the first-line therapy for ...

sequestrants, or absorption inhibitors. Table 1 The primary end point was the observed change in fasting lipid panel components after converting from atorvastatin to another formulary statin.

Please provide your email address to receive an email when new articles are posted on . “Current [osteoarthritis (OA)] therapies have short-term, small to moderate effects on joint pain; there is no ...